ラテン系およびアフリカ系の新参者に対する COVID-19 パンデミックのさまざまなメンタルヘルスへの影響に対処するための介入 (RIWP+)
ラテン系移民とアフリカ難民に対するCOVID-19パンデミックの構造的不公平と有害で異なる結果に対処するためのマルチレベルのコミュニティベースのメンタルヘルス介入
This study tests the effectiveness of a community-based peer advocacy, mutual learning, and social support intervention (Refugee and Immigrant Well-being Project) to reduce several negative consequences of the COVID-19 pandemic that are disproportionately impacting Latinx and Black populations: psychological distress, financial problems, and daily stressors. In partnership with five community-based organizations that focus on mental health, legal, education, and youth issues with Latinx immigrants and African refugees, we will also be able to examine the effects of people's involvement with community-based organizations and local and state policy changes on their mental health, economic stability, stressors, and social support. This is important not only for Latinx and Black populations and the large number of immigrants and refugees in the United States and worldwide, but also because the intervention model and what we learn from this study have the potential to alleviate mental health disparities experienced by other marginalized populations who face unequal access to social and material resources, disproportionate exposure to trauma and stress, and worse consequences of the COVID-19 pandemic.
調査の概要
状態
詳細な説明
The goal of this study is to test a multilevel approach to reduce adverse consequences of the COVID-19 pandemic with disparate impacts on Latinx and Black immigrants and refugees by observing and implementing three nested levels of intervention: 1) an efficacious 6-month peer advocacy and mutual learning model (Refugee and Immigrant Well-being Project, RIWP); 2) engagement with community-based organizations (CBOs); and 3) structural policy changes expected to be enacted in response to the pandemic, such as a state disaster relief proposal for mixed status Latinx families and expanded statewide health insurance coverage. This community-based participatory research (CBPR) study builds on a long-standing collaboration with five community-based organizations (CBOs) that focus on mental health, education, legal issues, and system change efforts to improve the well-being of Latinx immigrants and African refugees. By including 240 Latinx immigrants and 60 African refugees recruited from CBO partners who are randomly assigned to treatment-as-usual CBO involvement or the RIWP intervention and a random sample comparison group of 900 Latinx immigrants, this mixed methods longitudinal waitlist control group design study with five time points over 28 months will test the effectiveness of the RIWP intervention and engagement with CBOs to reduce psychological distress, daily stressors, and economic precarity and increase protective factors (social support, critical awareness of/access to resources, English proficiency, cultural connectedness, and mental health service use). This study will also test the ability of the RIWP intervention and engagement with CBOs to increase access to the direct benefits of structural interventions (local/state relief-related policies) for Latinx and Black immigrants and refugees. Mechanisms of intervention effectiveness will be explored by testing mediating relationships between primary outcomes and protective factors. Investigators will also track local/state policy changes and obtain preliminary quantitative estimates of effects of these structural interventions on psychological distress, stressors, and economic precarity using propensity score matching. Qualitative interview data from a purposive subsample of participants and CBO staff will enable additional exploration of mechanisms of change, the effects of policy interventions on individuals, how CBOs contribute to enacting policies and helping people benefit from them, and the context of RIWP implementation at each site. This research is innovative and significant because it employs cutting-edge research design and intervention strategies to advance the science of multilevel mental health interventions that aim to understand and address underlying structural inequities and resulting mental health disparities that have been highlighted and exacerbated by the pandemic. Thus, this study will contribute not only to reducing the disparate adverse mental health, behavioral, and socioeconomic consequences of the COVID-19 pandemic but also to eliminating mental health disparities among Latinx and Black populations.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
New Mexico
-
Albuquerque、New Mexico、アメリカ、87131
- University of New Mexico
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- All Latinx immigrants and African refugees aged 18 and older residing in New Mexico will be eligible to participate.
Exclusion Criteria:
- For the random sample of 1000 Latinx immigrants, exclusion criteria will be having used the services of one of the four community-based partner organizations serving Latinx immigrants within the past year (at time of study enrollment). For the 240 Latinx immigrants and 60 African refugees recruited through the five community-based organizations, exclusion criteria will be severe cognitive functioning problems or mental illness that is so severe as to impede participation in a group and that warrants immediate individual treatment.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:階乗代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
介入なし:Random Sample of Latinx Immigrants
random sample comparison group of Latinx immigrants who are NOT randomly assigned to a treatment condition |
|
|
実験的:Refugee & Immigrant Well-being Project (RIWP) Intervention
6-month mental health intervention that pairs university students with newcomers to engage in mutual learning, resource mobilization, and social change efforts |
6-month mental health intervention that pairs university students with newcomers to engage in mutual learning, resource mobilization, and social change efforts
他の名前:
|
|
介入なし:Treatment-as-usual Waitlist Control Group
participants recruited from community-based organizations receive usual services from community-based organizations and may participate in RIWP intervention in Year 3 |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Psychological Distress
時間枠:All 7 timepoints over 36 months
|
DSM Level 1 Cross-Cutting Symptom Measure-Adult and COVID-19 and Mental Health Impacts Scale (from PhenX Toolkit) |
All 7 timepoints over 36 months
|
|
Psychological Distress
時間枠:All 7 timepoints over 36 months
|
PHQ-9 |
All 7 timepoints over 36 months
|
|
Psychological Distress
時間枠:All 7 timepoints over 36 months
|
GAD-7 |
All 7 timepoints over 36 months
|
|
Physical Health
時間枠:All 7 timepoints over 36 months
|
WHODAS-2 |
All 7 timepoints over 36 months
|
|
Daily Stressors
時間枠:All 7 timepoints over 36 months
|
Perceived Stress Scale |
All 7 timepoints over 36 months
|
|
Economic Precarity
時間枠:All 7 timepoints over 36 months
|
Job Insecurity General Social Survey 2018 Questions and RAND American Life Panel Impacts of COVID-19 Survey |
All 7 timepoints over 36 months
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Access to Resources
時間枠:All 7 timepoints over 36 months
|
Satisfaction with Resources Scale |
All 7 timepoints over 36 months
|
|
Social Support
時間枠:All 7 timepoints over 36 months
|
Medical Outcomes Study Social Support Survey, 8-item version |
All 7 timepoints over 36 months
|
|
Cultural Connectedness
時間枠:All 7 timepoints over 36 months
|
Language, Identity, and Behavior Acculturation Scale |
All 7 timepoints over 36 months
|
|
Health Services Use
時間枠:All 7 timepoints over 36 months
|
Composite International Diagnostic Interview (selected questions) |
All 7 timepoints over 36 months
|
|
English Proficiency
時間枠:All 7 timepoints over 36 months
|
4 items about understanding, reading, speaking, and writing |
All 7 timepoints over 36 months
|
|
Discrimination
時間枠:All 7 timepoints over 36 months
|
Experience of Discrimination (EOD) Scale |
All 7 timepoints over 36 months
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- 07521
- R01MH127733 (米国 NIH グラント/契約)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
After all analyses are completed and presentations/publications are finalized, a de-identified dataset will be available to other researchers, communities, or providers, upon request. All requests would have to be approved by the Community Advisory Council and would have to demonstrate that the proposed use of the data would contribute to the reduction of mental health disparities (e.g., through improved detection, diagnosis, treatment or prevention of mental illness or through contributing to knowledge of these issues) and would not harm any individuals or communities (e.g., through naïve use of the data that might result in misrepresentation of the experiences of Latinx immigrants or African refugee individuals, families, or communities).
Also, the data will be entered and available through the NIMH Data Archive.
IPD 共有時間枠
Within 6 months of the end of data collection in Year 4
IPD 共有アクセス基準
The NDA provides basic descriptive and aggregate summary information for general public use. Such summary information may include summary counts and general statistics on completed assessment instruments. Access to subject level datasets submitted and stored in the NDA will only be provided for research purposes through the completion of the NDA Data Use Certification: OMB Control Number: 0925-0667. For the majority of the data available in the NDA, Data Use Certifications will only be accepted from researchers who are sponsored by an institution registered in the NIH's eRA Commons with an active Federal-wide Assurance issued through the Office for Human Research Protections (OHRP). Additionally, the application must include a reason for access related to scientific investigation, scholarship or teaching, or other form of research.
IPD 共有サポート情報タイプ
- STUDY_PROTOCOL
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。